Skip to content

Clinical trials

Phase 2 Hematologic Neoplasms trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 2 Country / region: Denmark Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20161
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
Fred Hutchinson Cancer Center1
Kyowa Kirin Co., Ltd.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms5
Lymphoma, Non-Hodgkin2
Waldenstrom Macroglobulinemia2
Anemia, Refractory, with Excess of Blasts1
Glioblastoma1
Granuloma, Plasma Cell1
Hodgkin Disease1
Leukemia, B-Cell1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Acute1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.